Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders

NCT06155201 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12000

Last updated 2023-12-04

No results posted yet for this study

Summary

The prevalence of mental disorders and developmental behavioral disorders (such as depressive disorders,anxiety disorders, autism spectrum disorders,attention deficit disorder,ect.)among children and adolescents in China is increasing,leading to difficulty in early identification of children and poor diagnosis and treatment effects,which brings significant financial burden to the families and the country.We will carry out a multi-center epidemiological survey on common mental disorders above among children and adolescents in Sichuan-Chongqing region and clarify the prevalence,geographical distribution and demographic characteristics.A total of more than 12,000 children and adolescents under 18 years old with a diagnosis of depression/anxiety disorders/ASD/ADHD based on DSM-5 criteria is included to build a research platform and database,so that we will formulate intelligence diagnosis and treatment standards.This study will establish the "Children and Adolescents Mental and Developmental Disabilities Innovation Alliance" in Sichuan and Chongqing areas and finally build intelligent early warning,diagnosis and intervention systems for disease in hope that technology transformation to be promoted and applied.

Conditions

  • Depressive Disorder
  • AD
  • ASD
  • ADHD

Interventions

BEHAVIORAL

functional training

Based on individual differences, children are provided with structural psychological behavioral therapy, including the implementation of aerobic exercise and executive skills training based on motivational quotient theory. Use brain imaging, brain functional imaging and neuromodulation technology to improve children's symptoms.

OTHER

Observation

Children with depressive disorders, anxiety disorders, autism spectrum disorders, and attention deficit hyperactivity disorder were recruited at presentation. Differential interventions and assessments were conducted during the study.

Sponsors & Collaborators

  • Southwest University, China

    collaborator UNKNOWN
  • Sichuan University ,China

    collaborator UNKNOWN
  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • Dachuan District People's Hospital,China

    collaborator UNKNOWN
  • Chongqing Beiminglian Digital Technology Co. LTD,China

    collaborator UNKNOWN
  • Chen Li

    lead OTHER

Principal Investigators

  • Li Chen, doctor · Children's Hospital of Chongqing Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06155201 on ClinicalTrials.gov